Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pyxis Oncology Inc
(NQ:
PYXS
)
3.710
+0.060 (+1.64%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pyxis Oncology Inc
< Previous
1
2
3
Next >
Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update
November 07, 2023
From
Pyxis Oncology
Via
GlobeNewswire
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review
October 13, 2023
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:PYXS),(NASDAQ:AZN),(NYSE:LLY),(NASDAQ:MRUS) EQNX::TICKER_END
Via
FinancialNewsMedia
Exposures
Product Safety
NASDAQ:PYXS Investor Notice: Investigation over Possible Securities Laws Violations by Pyxis Oncology, Inc.
October 05, 2023
San Diego, CA -- (SBWIRE) -- 10/05/2023 -- Pyxis Oncology, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer (SITC) 2023
September 27, 2023
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology M&A Spotlight Signals Potential Growth Amidst Competitive ADC Landscape: Analyst
September 05, 2023
RBC Capital Markets has initiated coverage on Pyxis Oncology Inc (NASDAQ: PYXS) with an Outperform rating and a
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 5, 2023
September 05, 2023
Via
Benzinga
Pyxis Oncology to Participate in Two Upcoming Investment Conferences
August 31, 2023
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology Successfully Completes Acquisition of Apexigen
August 23, 2023
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update
August 11, 2023
From
Pyxis Oncology
Via
GlobeNewswire
Pyxis Oncology to Present at BTIG Virtual Biotechnology Conference
August 01, 2023
From
Pyxis Oncology
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
July 31, 2023
Via
Benzinga
Small SPAC Biotech Apexigen To Be Acquired Pyxis Oncology For $16M
May 24, 2023
Via
Benzinga
Pyxis Oncology Bolsters Oncology Portfolio Through $16M Apexigen Acquisition
May 24, 2023
Pyxis Oncology (NASDAQ:PYXS) has announced an acquisition of Apexigen (NASDAQ:APGN) that is expected to be completed in the second half of 2023.
Via
Benzinga
Why Is Apexigen (APGN) Stock Up 31% Today?
May 24, 2023
Apexigen (APGN) stock is rising higher on Wednesday following news of a $16 million acquisition deal with Pyxis Oncology (PYXS).
Via
InvestorPlace
Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
April 05, 2023
Gainers RiceBran Technologies (NASDAQ: RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday.
Via
Benzinga
Why Bullfrog AI Holdings Shares Are Trading Higher By 73%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 04, 2023
Gainers Secoo Holding Limited (NASDAQ: SECO) shares surged 138% to $1.43.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 03, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 31, 2023
Via
Benzinga
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
March 31, 2023
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter.
Via
Benzinga
Top 5 Health Care Stocks That May Collapse
March 31, 2023
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 30, 2023
Via
Benzinga
Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket
March 29, 2023
Gainers LogicMark, Inc. (NASDAQ: LGMK) shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 28, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 27, 2023
Via
Benzinga
Why Jounce Therapeutics Shares Are Trading Higher By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 27, 2023
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 59.6% to $0.2513. Crown Electrokinetics said it has entered into an agreement with a leading infrastructure solutions provider.
Via
Benzinga
US Stocks Open Higher; Dow Rises 200 Points
March 27, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Monday. Following the market opening Monday, the Dow traded up 0.64% to 32,443.64 while the NASDAQ rose 0.20% to...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 27, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
March 24, 2023
It's time to start off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Friday!
Via
InvestorPlace
Why GameStop Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket
March 22, 2023
Gainers
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
March 22, 2023
The biggest pre-market stock movers are making waves on Wednesday with huge gainers and losers worth watching this morning!
Via
InvestorPlace
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.